Effect of bcr/abl fusion gene siRNA on proliferation and apoptosis of K562 cells
Jianwei Jiang
Abstract
Jianwei Jiang
Abstract
Objective To investigate the effect of bcr/abl fusion gene small interfering RNA(siRNA)on the proliferation and apoptosis of chronic myelogenous leukemia(CML)K562 cells.Methods A 21nt siRNA targeting b3:a2 mRNA of bcr/abl fusion gene was designed,synthesized,and transfected into K562 cells.The proliferation inhibition rate was measured by WST-8 method;The expression of bcr/abl mRNA of K562 cells was detected by RT-PCR;The cell cycle was determined by Phosphatidylinositol(PI)staining;The apoptosis rate was detected by Annexin V-fluorescencein isothiocyanate/phosphatidylinositol(PI)double staining;The morphology of apoptosis was examined by Hochest 33258 staining.Results ①Bcr/abl siRNA significantly inhibited K562 cells proliferation 24 h,48 h and 72 h after transfection.②Bcr/abl siRNA significantly down-regulated mRNA expression level.There was no significant difference between among different concentration bcr/abl siRNA groups(P0.05).③Cell cycle of K562 cells was blocked in G1 phase after bcr/abl siRNA transfection.④Apoptotic cells appeared early after bcr/abl siRNA transfection.The early apoptotic rates were not significantly different among different concentration bcr/abl siRNA groups(P0.05).Cells presented karyopyknoses,nuclear-set and apoptotic bodies.Conclusion The specific bcr/abl fusion gene siRNA significantly inhibits the expression of bcr/abl fusion gene,inhibits K562 cell proliferation and induces its apoptosis,but the efficacy was not dose-dependent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of bcr/abl fusion gene small interfering RNA(siRNA)on the proliferation and apoptosis of chronic myelogenous leukemia(CML)K562 cells.Methods A 21nt siRNA targeting b3:a2 mRNA of bcr/abl fusion gene was designed,synthesized,and transfected into K562 cells.The proliferation inhibition rate was measured by WST-8 method;The expression of bcr/abl mRNA of K562 cells was detected by RT-PCR;The cell cycle was determined by Phosphatidylinositol(PI)staining;The apoptosis rate was detected by Annexin V-fluorescencein isothiocyanate/phosphatidylinositol(PI)double staining;The morphology of apoptosis was examined by Hochest 33258 staining.Results ①Bcr/abl siRNA significantly inhibited K562 cells proliferation 24 h,48 h and 72 h after transfection.②Bcr/abl siRNA significantly down-regulated mRNA expression level.There was no significant difference between among different concentration bcr/abl siRNA groups(P0.05).③Cell cycle of K562 cells was blocked in G1 phase after bcr/abl siRNA transfection.④Apoptotic cells appeared early after bcr/abl siRNA transfection.The early apoptotic rates were not significantly different among different concentration bcr/abl siRNA groups(P0.05).Cells presented karyopyknoses,nuclear-set and apoptotic bodies.Conclusion The specific bcr/abl fusion gene siRNA significantly inhibits the expression of bcr/abl fusion gene,inhibits K562 cell proliferation and induces its apoptosis,but the efficacy was not dose-dependent.
Key concepts: K562 cells, Transfection, ABL, Apoptosis, Small interfering RNA, Molecular biology, Fusion gene, Chronic myelogenous leukemia